Pulmonary embolism: FDA reporting patterns
94,181 FDA FAERS reports mention Pulmonary embolism. 93,505 reports have a serious outcome flag.
Medicines named as suspect
- Ethinyl Estradiol: 16,164 reports
- Drospirenone: 9,707 reports
- Rivaroxaban: 4,693 reports
- Etonogestrel: 4,112 reports
- Lenalidomide: 3,983 reports
- Apixaban: 2,939 reports
- Adalimumab: 2,414 reports
- Testosterone: 2,341 reports
- Rofecoxib: 2,306 reports
- Rituximab: 2,273 reports
- Bevacizumab: 2,111 reports
- Prednisone: 2,024 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.